OA13.02 Two Novel Immunotherapy Agents Targeting DLL3 in SCLC: Trials in Progress of AMG 757 and AMG 119

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.12-03 Targeting DLL3 With AMG 757, a BiTE® Antibody Construct, and AMG 119, a CAR-T, for the Treatment of SCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Bootstrap AMG for Spectral Clustering

Computational and Mathematical Methods
2019English

Computing Interpolation Weights in AMG Based on Multilevel Schur Complements

Computing (Vienna/New York)
Numerical AnalysisComputational TheoryComputer Science ApplicationsComputational MathematicsMathematicsTheoretical Computer ScienceSoftware
2004English

AMG Volume 33 Issue 2 Cover and Front Matter

Acta geneticae medicae et gemellologiae: twin research
1984English

AMG Volume 37 Issue 2 Cover and Back Matter

Acta geneticae medicae et gemellologiae: twin research
1988English

AMG Volume 16 Issue 2 Cover and Front Matter

Acta geneticae medicae et gemellologiae
1967English

AMG Volume 10 Issue 2 Cover and Front Matter

Acta geneticae medicae et gemellologiae
1961English

P3.12-02 Dynamics of DLL3 and ASCL1 Expression in SCLC Over Disease Course

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

AMG Volume 25 Issue 1 Cover and Front Matter

Acta geneticae medicae et gemellologiae
1976English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy